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Laser microdissectionGranulocyte-colony stimulating factor (G-CSF) has been recently identiﬁed as a neurotrophic factor able to pre-
servemotor functions, rescuemotor units and extent survival in an animalmodel of amyotrophic lateral sclerosis,
the SOD1 G93Amice. To gain insight into themode of action of G-CSF, we have recently performed gene expres-
sion proﬁling on isolated lumbar motoneurons from SOD1G93A mice, and shown that G-CSF re-adjusted gene
expression in motoneurons of symptomatic SOD1G93A mice and modulates genes related to neuromuscular
function (Henriques et al., 2015). Here, we provide quality controls for themicroarray experiment (GO accession
number GSE60856) and describe the experimental strategy.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).SpeciﬁcationsOrganism/cell
line/tissueMus musculus, laser capture spinal motoneuronsSex Females
Sequencer or array type Affymetrix, GeneChip® mouse genome 430 2.0 array
Data format Raw data (cel ﬁles)
Experimental factors Isolated motoneurons from SOD1 G93A mice with or
without pharmacological treatment based on G-CSF.
Experimental features Combined laser microdissection, gene expression
proﬁling to study motoneuron speciﬁc expression in an
animal model of ALS, with and without neuroprotective
treatment based on G-CSF.Consent N/A
Sample source location N/ADirect link to deposited data
Deposited data can be found at: http://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE60856.de médecine, 11 rue Humann,
3 368853065.
. This is an open access article underExperimental design, materials and methods
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease
characterized by the death of cortical, bulbar and spinal motoneurons.
G-CSF is a hematopoietic growth factor with neuroprotective properties
for motoneurons [2,3]. Many studies have undertaken the study of the
transcriptome of tissues or isolated cells from animal models or ALS
patients [4]. The aim of the original study was to identify for the ﬁrst
time the transcriptional changes in motoneurons from SOD1 G93A
mice upon G-CSF treatment [1].Mice and treatment
Two cohorts of mice have been used within the study. A ﬁrst cohort
consisted of SOD1G93A mice and non-transgenic littermates of
11 weeks of age. These mice were used to detect early transcriptional
response due to the SOD1 G93A transgene. The second cohort of mice
consisted of SOD1 G93A and non-transgenic mice receiving the vehicle
solution (250 mM sorbitol, 0.004% Tween-80 and 10 mM sodium
acetate buffer (pH 4)), alongwith a group of SOD1 G93Amice receiving
G-CSF (30 μg/kg/day). This cohort was included in order to detect
transcripts deregulated by ALS and transcripts modulated by G-CSF.
The administration of vehicle or treatment was achieved by osmotic
pumps, from week 11 to week 15. After the sacriﬁce, lumbar spinal
cords were dissected and snap frozen.the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Special care was taken to avoid contamination with RNases. We
have dissected 300 motor neurons per mouse using the Leica Laser
Microdissection technology. Total RNA was extracted and ampliﬁed.
Microarray was performed using the GeneChip® mouse genome
430 2.0 array from Affymetrix. Intensities were normalized using
the Expression Console software from Affymetrix (http://www.
affymetrix.com/estore/browse/level_seven_software_products_only.
jsp?productId=131414).Fig. 2. Relative fold enrichment in motoneuron mRNA. Given is the relative fold enrich-
ment in mRNA from motoneurons, as determined by the ratio between neuroﬁlament-
heavy chain expression value and other genes speciﬁc for one cell types (GFAP for astro-
cytes; Sox10 for oligodendrocytes; Aif1l for microglial cells; Cldn5 for endothelial cells).Quality controls and analytical sequence
The efﬁcacy of the intensity normalization was assessed with box
plots showing probe cell intensity before normalization and relative
probe cell intensity after normalization (Fig. 1A, B). After normalization,
variability among arrays was strongly reduced, as monitored by the
nearness between the median of log expression signals from each
samples to the median array of all samples (red line, Fig. 1B).
Enrichment in mRNA from motoneurons was assessed by com-
paring the relative expression of cell speciﬁc genes [motoneurons:
neuroﬁlament-heavy chain (Nefh); astrocytes: glial ﬁbrillary acidic
protein (gfap); oligodendrocytes: SRY (sex determining region Y)-
box 10(Sox10); microglia: allograft inﬂammatory factor 1-like
(Aif1l); endothelial cells: claudin 5(Cldn5)] [5].
Based on the ratios between Nefh and the other cell speciﬁc tran-
scripts, the laser microdissection led to an enrichment of motoneuronal
mRNA estimated to a 135-fold as compared to astrocyte mRNA, to an
82-fold as compared to oligodendrocyte mRNA, to a 214-fold asFig. 1. Expression signal normalization. Expression signal before (A) and after normalizati
median of all arrays.compared to microglia mRNA and to a 384-fold as compared to endo-
thelial mRNA (Fig. 2).
Principal component analysis (JMP 11.0.0, SAS Institute, Cary, North
Carolina) was performed with the 1279 genes showing a standard
deviation higher than 1.1 across all array to assess homogeneity
among samples (Fig. 3). Age had a strong inﬂuence on the distribution
of samples as shown by the segregation between samples from
11 weeks and 15 weeks old mice, regardless of the genotype.
At 15weeks of age, samples from SOD1 G93Amice presented strong
dispersion, presumably due to the variability of the pace of disease
progression. It can be noted that ﬁve samples from the G-CSF treatedon (B) by Affymetrix Expression Console software. The red line in panel B shows the
Fig. 3. Principal component analysis. Given is the distribution of samples based on their
global transcriptomic proﬁles. Non-transgenic mice are represented by black (11 weeks
old) and gray (15 weeks old) dots. SOD1 G93A mice are represented by orange
(11 weeks), red (15 weeks, placebo) and green (15 weeks, G-CSF treated) dots.
49A. Henriques et al. / Genomics Data 4 (2015) 47–49mice regrouped together and were close to the non-transgenic or
asymptomatic SOD1 G93A clusters. Samples from the placebo-treated
SOD1G93Amice presented the strongest dispersion. These data suggest
that G-CSF had a substantial effect on the transcriptome of SOD1 G93A
motoneurons.
Prior to supervised analysis, gene expression database was ﬁltered
for intensity signal (at least 4 arrays showed an intensity higher than
centile 0.2) to remove background noise and for variability (standard
deviation higher than centile 0.3) to discard transcripts with no or little
changes in the expression across all arrays.Discriminant analysis was used to determine how samples from
SOD1 G93A mice treated with G-CSF relate to the other experimental
groups. Only transcripts showing a standard deviation greater than 1.2
across all arrays were included in this analysis.
In an attempt to identify speciﬁc transcriptomic deregulation with
biological relevance by ANOVA, we applied another ﬁltering step,
consisting in removing all transcripts with a fold-change expression
lower than 1.2 when comparing non-transgenic and SOD1 G93A
samples. The results generated by the discriminant analysis and by
ANOVA are detailed in the original manuscript [1].
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